immunization Flashcards

(46 cards)

1
Q

The process of making a person immune to a disease, typically through vaccine administration.

A

Immunization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Stimulates the immune system to produce antibodies (e.g., vaccines).

A

Active Immunization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Provides temporary immunity by administering pre-formed antibodies (e.g., antiserum).

A

Passive Immunization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A biological preparation that provides active immunity against a specific disease.

A

Vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Contains weakened live pathogens (e.g., MMR, Varicella).

A

Live Attenuated Vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Uses killed pathogens (e.g., Rabies, Hepatitis A).

A

Inactivated Vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Contains inactivated bacterial toxins (e.g., Tetanus, Diphtheria).

A

Toxoid Vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Community protection achieved when a high percentage of the population is immunized.

A

Herd Immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Blood serum containing antibodies for passive immunity (e.g., snake venom antiserum).

A

Antiserum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Any untoward medical occurrence after vaccination.

A

Adverse Event Following Immunization (AEFI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Training program certifying pharmacists to administer vaccines.

A

Immunizing Pharmacist Certification Program (IPCP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Identifying vaccine needs during specific events (e.g., hospital admission).

A

Occurrence Screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Assessing vaccine needs based on medical conditions (e.g., diabetes).

A

Diagnosis Screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Patient’s voluntary agreement to vaccination after understanding risks/benefits.

A

Informed Consent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pharmacist’s role in selecting and recommending vaccines for institutional use.

A

Formulary Management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

body’s defense system

A

immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Vaccine Action Steps

A

Antigen Introduction

Immune Response Activation

Memory Formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

First vaccine (smallpox) by Edward Jenner

20
Q

Louis Pasteur developed rabies vaccine

21
Q

Polio, measles, HPV, and COVID-
19 vaccines

A

20th-21st Century

22
Q

vaccines stimulate the body’s natural defense mechanisms (immune system).

A

active immunization

23
Q

Occurs when a person is natur ally exposed to a pathogen and becomes infected.

A

Natural Active Immunization

24
Q

Occurs when a person is intentionally exposed to a pathogen through a vaccine.

A

Artificial Active Immunization

25
• Used when: -The immune system doesn't respond adequately -Infection occurs before vaccination is possible -Immediate protection is needed (e.g., after rabies exposure)
PASSIVE IMMUNIZATION
26
Antibodies passed from mother to fetus or infant.
Natural Passive Immunization
27
• Prepared antibodies from external sources. • Used during high risk of infection or when there's not enough time for the immune system to respond.
Artificial Passive Immunization
28
- human or non-human blood serum containing polyclonal antibodies - mixture of antibodies efficient against a variety of different epitopes of antigen
Antiserum
29
- human or non-human blood serum containing antibodies derived from single activated B-cell clone
Monoclonal Antibodies
30
lack pathogenicity bur retain apacity for transient growth in host body • single dose is sufficient
Live attenuated vaccine
31
• contain pathogens killed by heat or chemicals • Lack capability to replicate but retain pathogenicity
Inactivated or killed vaccine
32
• contain inactivated and purified exotoxins produced by some bacteria (e.g., Mycobacterium diphtheride, Mycobacterium tetani)
Toxoid vaccine
33
• Contain gene encoding antigenic proteins of pathogen cloned with plasmid
DNA vaccine
34
Importance of Immunization
Disease Prevention Protection of the Community (Herd Immunity) • Reduction of Healthcare costs • Control and Elimination of Diseases • Faster Recovery from Outbreaks • Global Health Impact and Disease Eradication
35
36
37
• vaccine needs are identified at the time of particular events, such as hospital or nursing home admission or discharge, ambulatory care or emergency room visits, mid-decade birthdays (e.g., years 25, 35, and 45), and any contact with a health care delivery system for patients under 8 years or over 50 years of age.
Occurrence screening
38
39
vaccine needs of patients with conditions that increase their risk of preventable infections.
Diagnosis screening
40
• Immunization needs are assessed on the basis of medical or surgical procedures using this type of screening.
Procedure screening
41
• a comprehensive assessment of immunization adequacy in selected populations at a given time. Such screening may be conducted, for example, during autumn influenza programs or outbreaks of certain vaccine-preventable illnesses (e.g., measles and meningococcal disease).
Periodic mass screening
42
Focuses on the immunization needs of health care workers at risk of exposure to vaccine-preventable diseases or high-risk patients.
Occupational screening
43
CHALLENGES OF COMMUNITY PHARMACY IN VACCINATION
Challenges Reimbursement Challenges Technology
44
Empowers licensed pharmacists to administer adult vaccines upon completion of accredited training and certification programs.
Republic Act No. 10918 (Philippine Pharmacy Act of 2016)
45
Accredits the Philippine Pharmacists Association (PPhA) as the official training provider for the Immunizing Pharmacist Certification Program (IPCP).
Professional Regulation Commission (PRC) Resolution No. 05, Series of 2021
46
Developed by: Philippine Pharmacists Association (PPhA). • Objective: Equip pharmacists with the necessary knowledge and skills to sately administer vaccines to adults.
Immunizing Pharmacist Certification Program (IPCP)